Large granular lymphocyte leukemia
Active Research Protocols
- 04-C-0031 – Phase I Trial of Medi-507 in CD2-Positive Lymphoproliferative Disease
- 04-C-0089 – Phase I Open-Label Single-Dose Study of Humanized Mik-Beta-1 Monoclonal Antibody Directed Toward the IL-2R/IL-15R-Beta Subunit (CD122) in T Cell Large Granular Lymphocytic Leukemia
- 06-H-0190 – Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders with Alemtuzumab (Campath)
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014